For example, individuals with Lebers disease, a rare genetic disorder, may be at risk of optic nerve damage from B12 injections
It is noteworthy that non-coeliac patients also display morphological abnormalities in their intestinal barrier including reduced abundance, delocalisation, and functionality of enterocyte microvilli as well as displacement of TJ components, each of which is likely to contribute to increased intestinal permeability and disease pathogenesis (Secondulfo et al
Based on six clinical trials involving approximately 900 participants, AOD-9604 has demonstrated an excellent safety profile indistinguishable from placebo
Reported side effects Mild headache or fatigue typically transient during initial use Mild gastrointestinal discomfort reported in some oral formulation users Sleep disruption or irritability potential sign of overstimulation Theoretical safety concerns Critical note: Because Dihexa activates the HGF/c-Met pathway which promotes cellular growth and repair there is a theoretical concern that it could potentially stimulate unwanted cell proliferation in individuals with active cancer or high cancer risk
Its small size confers favorable physicochemical properties for solubility, stability, and intranasal or subcutaneous delivery, but also raises questions about specificity that are common to short peptides in vivo proteolytic stability, off-target binding, and minimum receptor recognition motif identification all require additional characterization that the published literature does not yet fully provide
Each peptide presents a unique opportunity to study how hormonal systems interact to govern appetite, glucose metabolism, and energy balance
